Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (924)
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
63,907
Price
$61.99
Total Value
$3.96M
Shares Held After
130,488
% of Holdings
32.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,431
Price
$65.31
Total Value
$93.46K
Shares Held After
117,066
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
1,400
Price
$63.65
Total Value
$89.11K
Shares Held After
118,497
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
27,421
Price
$62.59
Total Value
$1.72M
Shares Held After
119,897
% of Holdings
18.6%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
71,938
Price
$62.05
Total Value
$4.46M
Shares Held After
147,318
% of Holdings
32.8%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
400
Price
$40.45
Total Value
$16.18K
Shares Held After
36,108
% of Holdings
1.1%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
600
Price
$40.38
Total Value
$24.23K
Shares Held After
9,900
% of Holdings
5.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
4,712
Price
$39.68
Total Value
$186.97K
Shares Held After
36,508
% of Holdings
11.4%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
4,338
Price
$39.65
Total Value
$172.00K
Shares Held After
10,500
% of Holdings
29.2%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
1,195
Price
$27.00
Total Value
$32.27K
Shares Held After
395,794
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Karydas Daphne — Director
Shares
3,000
Price
$28.58
Total Value
$85.74K
Shares Held After
6,200
% of Holdings
32.6%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
6,657
Price
$17.03
Total Value
$113.40K
Shares Held After
213,476
% of Holdings
3.0%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
3,328
Price
$17.03
Total Value
$56.69K
Shares Held After
220,133
% of Holdings
1.5%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM&MEDICAL AFFAIRS
Shares
3,329
Price
$17.03
Total Value
$56.71K
Shares Held After
223,461
% of Holdings
1.5%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
66
Price
$80.01
Total Value
$5.28K
Shares Held After
94,487
% of Holdings
0.1%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
759
Price
$79.00
Total Value
$59.96K
Shares Held After
94,553
% of Holdings
0.8%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
11,675
Price
$78.33
Total Value
$914.50K
Shares Held After
95,312
% of Holdings
10.9%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
100,000
Price
$13.67
Total Value
$1.37M
Shares Held After
467,969
% of Holdings
17.6%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
13,985
Price
$120.49
Total Value
$1.69M
Shares Held After
183,200
% of Holdings
7.1%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
9,233
Price
$120.50
Total Value
$1.11M
Shares Held After
197,185
% of Holdings
4.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$24.18
Total Value
$114.37K
Shares Held After
35,841
% of Holdings
11.7%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
1,400
Price
$39.24
Total Value
$54.94K
Shares Held After
39,068
% of Holdings
3.5%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
45,000
Price
$38.14
Total Value
$1.72M
Shares Held After
40,468
% of Holdings
52.7%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
8,667
Price
$38.27
Total Value
$331.72K
Shares Held After
10,500
% of Holdings
45.2%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
54,256
Price
$1.30
Total Value
$70.45K
Shares Held After
883,761
% of Holdings
6.1%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$96.49
Total Value
$3.28M
Shares Held After
568,209
% of Holdings
5.6%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
40,281
Price
$146.07
Total Value
$5.88M
Shares Held After
1,562,029
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$504.57
Total Value
$327.97K
Shares Held After
324,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
845
Price
$503.80
Total Value
$425.71K
Shares Held After
325,093
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
825
Price
$502.57
Total Value
$414.62K
Shares Held After
325,938
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,689
Price
$501.66
Total Value
$1.35M
Shares Held After
326,763
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,711
Price
$500.68
Total Value
$1.86M
Shares Held After
329,452
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$499.77
Total Value
$389.82K
Shares Held After
333,163
% of Holdings
0.2%
Ginkgo Bioworks Holdings, Inc. (DNA)
HENRY CHRISTIAN O — Director
Shares
5,000
Price
$7.08
Total Value
$35.41K
Shares Held After
19,310
% of Holdings
20.6%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,800
Price
$111.70
Total Value
$312.77K
Shares Held After
1,064,543
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
400
Price
$110.84
Total Value
$44.33K
Shares Held After
1,067,343
% of Holdings
0.0%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
6,800
Price
$110.27
Total Value
$749.83K
Shares Held After
1,067,743
% of Holdings
0.6%
Phio Pharmaceuticals Corp. (PHIO)
BRADFORD PATRICIA A — Director
Shares
12,000
Price
$1.03
Total Value
$12.36K
Shares Held After
57,651
% of Holdings
20.8%
FENNEC PHARMACEUTICALS INC. (FENC)
Brughera Marco Maria — Director
Shares
15,545
Price
$10.29
Total Value
$159.96K
Shares Held After
0
% of Holdings
100.0%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
6,090
Price
$38.99
Total Value
$237.45K
Shares Held After
39,021
% of Holdings
13.5%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
22,000
Price
$0.22
Total Value
$4.86K
Shares Held After
91,822
% of Holdings
24.0%
TENAX THERAPEUTICS, INC. (TENX)
Giordano Christopher Thomas — Director
Shares
4,850
Price
$1.82
Total Value
$8.84K
Shares Held After
22,174
% of Holdings
21.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
560
Price
$151.33
Total Value
$84.74K
Shares Held After
160,116
% of Holdings
0.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
263
Price
$150.40
Total Value
$39.56K
Shares Held After
160,676
% of Holdings
0.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
954
Price
$149.38
Total Value
$142.51K
Shares Held After
160,939
% of Holdings
0.6%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
35,000
Price
$3.30
Total Value
$115.39K
Shares Held After
3,183,000
% of Holdings
1.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
560
Price
$95.71
Total Value
$53.60K
Shares Held After
14,752
% of Holdings
3.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
2,452
Price
$95.71
Total Value
$234.68K
Shares Held After
923,128
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
1,039
Price
$95.71
Total Value
$99.44K
Shares Held After
29,995
% of Holdings
3.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$95.71
Total Value
$90.64K
Shares Held After
31,771
% of Holdings
2.9%
Showing 451–500 of 924 transactions (page 10 of 19)